Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 456 results for "empa"

Cardiac, renal benefits shown in new diabetes drug studies

This drug reduces the risk of kidney disputes among type 2 dia...

BENGALURU: A recently conducted global study, EMPA-REG has revealed that the drug Empagliflozin reduces the risk for new onset or worsening kidney disease by 39% among patients suffering from Type 2 Diabetes with established cardiovascular diseases ... Times of India, 1 week ago

48 images for empa, 1 day ago
SleekMoney, 1 day ago
SleekMoney, 1 week ago
SleekMoney, 1 week ago
European Pharmaceutical Review, 2 weeks ago
Empa, 3 weeks ago
East Midlands Business News, 1 month ago
East Midlands Business News, 1 month ago
A2C2, 2 months ago, 2 months ago

Empire's (EMP.A) CEO Marc Poulin on Q4 2016 Results - Earnings Call Transcript

Empire Company Ltd. ( EMP.A ) Q4 2016 Earnings Conference Call June 29, 2016 7:00 AM ET Executives Clinton Keay - EVP of Finance François Vimard - CFO Marc Poulin - President and CEO Analysts Mark Petrie - CIBC World Markets ...
 Seeking Alpha2 days ago Empire Company Reports Q4 Results, Raises Dividend  BayStreet.ca1 day ago Empire Company Reports Fiscal 2016 Fourth Quarter and Full Year Results  WorldNetDaily3 days ago Media advisory - Empire Company Limited Advisory of Q4 and Full Year Fiscal 2016 Results Conference Call  Bloomberg2 weeks ago

EMPA, Long-term Load Test for Synthetic Reinforcement Fibers

The durability of synthetic fibers in aggressive environments is often questioned. A long-term test undertaken by the Swiss Material Testing and Research Institute (EMPA) as part of a KTI project (KTI 10652.1 PFIW-IW) has been able to disprove this ...
 Nbmcw.com1 month ago Innovative synthetic fibers as a substitute for steel fibers  Nbmcw.com1 month ago

Scotiabank Reaffirms Sector Perform Rating for Empire Company Limited (EMP.A)

Empire Company Limited (TSE:EMP.A)s stock had its sector perform rating reiterated by equities researchers at Scotiabank in a note issued to investors on Wednesday. They presently have a C$23.50 price objective on the stock. EMP.A has been the ...
 American Banking News2 days ago Empire Company Limited (EMP.A) Rating Reiterated by Scotiabank  WKRB News22 hours ago Empire Company Limited (EMP.A) Price Target Lowered to C$21.00 at Raymond James  Ticker Report22 hours ago Empire Company Limited (EMP.A) Lowered to Underweight at Barclays  Mideast Time22 hours ago

Lilly : FDA Panel Recommends Approval Of Jardiance For Cardiovascular Indication

The recommendation was made by the Endocrinologic and Metabolic Drugs Advisory Committee based on data from the landmark EMPA-REG OUTCOME trial, which found that JARDIANCE significantly reduced the risk of the combined endpoint of CV death, ...
 Nasdaq3 days ago FDA Votes to Change Jardiance Label to Show Reduction in Heart-Related Deaths  diaTribe1 day ago Jardiance CV Label Claim Is No Slam Dunk  Seeking Alpha1 day ago FDA advisory panel narrowly votes in favor of expanded approval for empagliflozin  Cardiovascular Business2 days ago

Investment Analysts Updated EPS Estimates for June, 30th (ACRE, DRII, EMP.A, GALE, HII, LUC, MON, ONE, SHPG, SNV)

Investment Analysts updated eps estimates for Thursday, June 30th: Ares Commercial Real Estate Corp (NYSE:ACRE) had its buy rating reissued by analysts at FBR & Co.. Diamond Resorts International (NYSE:DRII) was downgraded by analysts at MKM ...
 SleekMoney1 day ago

Maritime pilots praise port directive

The European Maritime Pilots Association (EMPA) is pleased and excited about the fact that the European Council has now approved the EU port directive, which has previously been subject to harsh criticism
 ShippingWatch1 day ago

Spotlight On: Diminishing returns from EMPA-REG but Jardiance's cardiovascular claim deserves to get over the finishing line

You attempted to read Spotlight On , exclusive content for FirstWord Pharma PLUS members. You currently are not registered for any FirstWord Pharma services. To gain instant access to Spotlight On plus additional enhanced content and features, ...
 FirstWord Pharma2 days ago
European Pharmaceutical Review

Empagliflozin slows progression of kidney disease

Further analysis of the EMPA-REG OUTCOME study shows that, in addition to its beneficial effects on cardiovascular disease and mortality, empagliflozin is associated with slower progression of kidney disease and lower rates of clinically relevant ...
 DiabetesontheNet.com1 week ago Latest drugs reduce risk of kidney disease: global study  The Freepress Journal6 days ago New data shows Jardiance reduces risk of kidney disease in people with type 2 diabetes with established CV disease  PharmaBiz2 weeks ago Lilly and Boehringer's Jardiance sets new bar, shows kidney benefit  BioPharma Dive2 weeks ago

Equities Research Analysts Updated EPS Estimates for June, 23rd (ASBFY, ATD.B, BBBY, CF, CNE, CP, EMP.A, ERF, ES, FDX)

Equities Research Analysts updated eps estimates for Thursday, June 23rd: Associated British Foods plc (OTCMKTS:ASBFY) was downgraded by analysts at Morgan Stanley from an overweight rating to an equal weight rating. Alimentation Couche-Tard ...
 SleekMoney1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less